BioCryst Pharmaceuticals | 员工 | 总数

金融业

USD

USD 446.42M

现金及等价物

USD 84.08M

USD 12.27M

USD 355.68M

USD 190.24M

USD 828.6M

股息收益率

0

USD -4.51M

USD -20.3M

536

EPS每股收益

USD -0.13

股本和储备

USD -387.89M

USD -88.88M

债务利息支出

USD 24.45M

USD -0.13

USD 194.37M

USD 1.3B

USD -88.88M

USD -387.89M

USD -2.54M

普通股股本

USD 1.9M

1.08K

USD -86.95M

USD -86.95M

销售和管理费用

USD 80.47M

USD 5.23M

贸易债权人

USD 5.57M

应收帐款人

USD 79.07M

	员工	更改		日
Alnylam Pharmaceuticals	2.23K		130	2024-12
BioCryst Pharmaceuticals	536		5	2023-12
Chugai Pharma	7.78K		174	2024-12
Daiichi Sankyo	19.76K		1.04K	2025-12
DBV Technologies	USD 104		19	2023-12
Enanta Pharmaceuticals	145		15	2023-09
Gilead Sciences	17.6K		400	2024-12
GlaxoSmithKline	69.4K		20.7K	2022-12
Glaxosmithkline	GBP 69.4K		20.7K	2022-12
Incyte	2.62K		93	2024-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Karyopharm Therapeutics	325		60	2023-12
Neurocrine Biosciences	1.8K		400	2024-12
Novavax	1.54K		449	2023-12
PTC Therapeutics	939		49	2024-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Roche Holding	103.61K		2.69K	2022-12
Sarepta Therapeutics	1.37K		58	2024-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vertex Pharmaceuticals	6.1K		700	2024-12

BioCryst Pharmaceuticals 员工总数 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.